ArticleERJ open research2025

The activin pathway in chronic thromboembolic pulmonary hypertension: a potential biomarker for residual pulmonary hypertension after endarterectomy.

Alessandra Cuomo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.